Christopher D Creech

Title: Christopher D. Creech: Innovator in Cyclic Nucleotide-Gated Ion Channels

Introduction

Christopher D. Creech is a notable inventor based in Garner, NC (US). He has made significant contributions to the field of biotechnology, particularly in the study of cyclic nucleotide-gated ion channels. With a total of 5 patents to his name, Creech's work has advanced our understanding of these important biological structures.

Latest Patents

Creech's latest patents include innovative methods for identifying modulators of cyclic nucleotide-gated cation channels. One of his inventions provides isolated nucleic acid and amino acid sequences of CNG2B, along with antibodies to CNG2B. This invention also outlines methods for detecting CNG2B and screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. Additionally, it includes a computer system method for screening mutations of human CNG2B genes and identifying the three-dimensional structure of human CNG2B polypeptides. Another significant patent focuses on cyclic nucleotide-gated cation channel subunit 3B (CNG3B), offering similar advancements in the detection and modulation of CNG3B.

Career Highlights

Christopher D. Creech is currently employed at Icagen, Inc., where he continues to push the boundaries of research in his field. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.

Collaborations

Creech collaborates with Timothy James Jegla, further enhancing the research efforts in the area of cyclic nucleotide-gated ion channels.

Conclusion

Christopher D. Creech is a prominent inventor whose work in cyclic nucleotide-gated ion channels has led to significant advancements in biotechnology. His contributions are vital for future research and potential medical applications.